The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials

Article reports that, should candidate vaccines attain emergency use designation and be programmatically deployed before their phase 3 trials conclude it could have far reaching consequences for COVID-19 vaccine research.

Source:

The Lancet Infectious Diseases